http://streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 16 Jun 2026 16:16:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Dermata+Therapeutics%2C+++++For%3A+Jun+16++Filed+by%3A+Scott+Kathleen+D./26654302.html si-local-file:///var/storage/secattach/20260616/26654302.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Dermata+Therapeutics%2C+++++For%3A+Jun+16++Filed+by%3A+Scott+Kathleen+D./26654302.html Tue, 16 Jun 2026 16:16:00 -0400 DRMA O.28730328 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Dermata+Therapeutics%2C+++++For%3A+Jun+16++Filed+by%3A+Scott+Kathleen+D./26654302.html si-local-file:///var/storage/secattach/20260616/26654302.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Dermata+Therapeutics%2C+++++For%3A+Jun+16++Filed+by%3A+Scott+Kathleen+D./26654302.html Tue, 16 Jun 2026 16:16:00 -0400 DRMA O.28730328 http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++Dermata+Therapeutics%2C++++++++++++++++/26605945.html si-local-file:///var/storage/secattach/20260604/26605945.html http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++Dermata+Therapeutics%2C++++++++++++++++/26605945.html Thu, 04 Jun 2026 16:16:00 -0400 DRMA O.28730328 http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++Dermata+Therapeutics%2C++++++++++++++++/26605945.html si-local-file:///var/storage/secattach/20260604/26605945.html http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++Dermata+Therapeutics%2C++++++++++++++++/26605945.html Thu, 04 Jun 2026 16:16:00 -0400 DRMA O.28730328 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13D++Dermata+Therapeutics%2C++++++++++++++++++Filed+by%3A+Van+Hoose+Kyri+K./26584400.html si-local-file:///var/storage/secattach/20260601/26584400.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13D++Dermata+Therapeutics%2C++++++++++++++++++Filed+by%3A+Van+Hoose+Kyri+K./26584400.html Mon, 01 Jun 2026 16:36:00 -0400 DRMA O.28730328 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13D++Dermata+Therapeutics%2C++++++++++++++++++Filed+by%3A+Van+Hoose+Kyri+K./26584400.html si-local-file:///var/storage/secattach/20260601/26584400.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13D++Dermata+Therapeutics%2C++++++++++++++++++Filed+by%3A+Van+Hoose+Kyri+K./26584400.html Mon, 01 Jun 2026 16:36:00 -0400 DRMA O.28730328 http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++Dermata+Therapeutics%2C++++++++++++++++/26578476.html si-local-file:///var/storage/secattach/20260601/26578476.html http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++Dermata+Therapeutics%2C++++++++++++++++/26578476.html Mon, 01 Jun 2026 06:07:00 -0400 DRMA O.28730328 http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++Dermata+Therapeutics%2C++++++++++++++++/26578476.html si-local-file:///var/storage/secattach/20260601/26578476.html http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++Dermata+Therapeutics%2C++++++++++++++++/26578476.html Mon, 01 Jun 2026 06:07:00 -0400 DRMA O.28730328 http://www.streetinsider.com/SEC+Filings/Form++424B3++++++Dermata+Therapeutics%2C++++++++++++++++/26576682.html si-local-file:///var/storage/secattach/20260529/26576682.html http://www.streetinsider.com/SEC+Filings/Form++424B3++++++Dermata+Therapeutics%2C++++++++++++++++/26576682.html Fri, 29 May 2026 17:25:00 -0400 DRMA O.28730328 http://www.streetinsider.com/SEC+Filings/Form++424B3++++++Dermata+Therapeutics%2C++++++++++++++++/26576682.html si-local-file:///var/storage/secattach/20260529/26576682.html http://www.streetinsider.com/SEC+Filings/Form++424B3++++++Dermata+Therapeutics%2C++++++++++++++++/26576682.html Fri, 29 May 2026 17:25:00 -0400 DRMA O.28730328 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Dermata+Therapeutics%2C+++++For%3A+May+27/26558838.html si-local-file:///var/storage/secattach/20260527/26558838.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Dermata+Therapeutics%2C+++++For%3A+May+27/26558838.html Wed, 27 May 2026 16:58:00 -0400 DRMA O.28730328 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Dermata+Therapeutics%2C+++++For%3A+May+27/26558838.html si-local-file:///var/storage/secattach/20260527/26558838.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Dermata+Therapeutics%2C+++++For%3A+May+27/26558838.html Wed, 27 May 2026 16:58:00 -0400 DRMA O.28730328 http://www.streetinsider.com/Equity+Offerings/Dermata+Therapeutics%2C+Inc+%28DRMA%29+files+%24100M+mixed+shelf/26542887.html <p>Dermata Therapeutics, Inc (NASDAQ: DRMA) has filed $100,000,000 mixed shelf of:<br /> </p><p>Common Stock</p><p>Preferred Stock</p><p>Warrants</p><p>Debt Securities</p><p>Subscription Rights</p><p>Units</p> http://www.streetinsider.com/Equity+Offerings/Dermata+Therapeutics%2C+Inc+%28DRMA%29+files+%24100M+mixed+shelf/26542887.html Fri, 22 May 2026 17:18:59 -0400 DRMA http://www.streetinsider.com/Corporate+News/Dermata+Therapeutics%2C+Inc+%28DRMA%29+files+%24100M+mixed+shelf/26542887.html <p>Dermata Therapeutics, Inc (NASDAQ: DRMA) has filed $100,000,000 mixed shelf of:<br /> </p><p>Common Stock</p><p>Preferred Stock</p><p>Warrants</p><p>Debt Securities</p><p>Subscription Rights</p><p>Units</p> http://www.streetinsider.com/Corporate+News/Dermata+Therapeutics%2C+Inc+%28DRMA%29+files+%24100M+mixed+shelf/26542887.html Fri, 22 May 2026 17:18:59 -0400 DRMA http://www.streetinsider.com/SEC+Filings/Form++S-3A++++++Dermata+Therapeutics%2C++++++++++++++++/26542859.html si-local-file:///var/storage/secattach/20260522/26542859.html http://www.streetinsider.com/SEC+Filings/Form++S-3A++++++Dermata+Therapeutics%2C++++++++++++++++/26542859.html Fri, 22 May 2026 17:16:00 -0400 DRMA O.28730328 http://www.streetinsider.com/SEC+Filings/Form++S-3A++++++Dermata+Therapeutics%2C++++++++++++++++/26542859.html si-local-file:///var/storage/secattach/20260522/26542859.html http://www.streetinsider.com/SEC+Filings/Form++S-3A++++++Dermata+Therapeutics%2C++++++++++++++++/26542859.html Fri, 22 May 2026 17:16:00 -0400 DRMA O.28730328 http://www.streetinsider.com/Earnings/Dermata+Therapeutics%2C+Inc+%28DRMA%29+Misses+Q1+EPS+by+48c/26487592.html <p>Dermata Therapeutics, Inc (NASDAQ: DRMA) reported Q1 EPS of ($0.48).</p><p>For earnings history and earnings-related data on Dermata Therapeutics, Inc (DRMA) <a href="http://www.streetinsider.com/ec_earnings.php?q=DRMA">click here</a>.</p> http://www.streetinsider.com/Earnings/Dermata+Therapeutics%2C+Inc+%28DRMA%29+Misses+Q1+EPS+by+48c/26487592.html Wed, 13 May 2026 17:20:52 -0400 DRMA http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Dermata+Therapeutics%2C++++++++++++++++++Filed+by%3A+INTRACOASTAL+CAPITAL%2C+LLC/26486973.html si-local-file:///var/storage/secattach/20260513/26486973.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Dermata+Therapeutics%2C++++++++++++++++++Filed+by%3A+INTRACOASTAL+CAPITAL%2C+LLC/26486973.html Wed, 13 May 2026 16:40:00 -0400 DRMA O.28730328 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Dermata+Therapeutics%2C++++++++++++++++++Filed+by%3A+INTRACOASTAL+CAPITAL%2C+LLC/26486973.html si-local-file:///var/storage/secattach/20260513/26486973.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Dermata+Therapeutics%2C++++++++++++++++++Filed+by%3A+INTRACOASTAL+CAPITAL%2C+LLC/26486973.html Wed, 13 May 2026 16:40:00 -0400 DRMA O.28730328 http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Dermata+Therapeutics%2C+++++For%3A+Mar+31/26485995.html si-local-file:///var/storage/secattach/20260513/26485995.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Dermata+Therapeutics%2C+++++For%3A+Mar+31/26485995.html Wed, 13 May 2026 16:08:00 -0400 DRMA O.28730328 http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Dermata+Therapeutics%2C+++++For%3A+Mar+31/26485995.html si-local-file:///var/storage/secattach/20260513/26485995.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Dermata+Therapeutics%2C+++++For%3A+Mar+31/26485995.html Wed, 13 May 2026 16:08:00 -0400 DRMA O.28730328 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Dermata+Therapeutics%2C+++++For%3A+Mar+31/26485894.html si-local-file:///var/storage/secattach/20260513/26485894.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Dermata+Therapeutics%2C+++++For%3A+Mar+31/26485894.html Wed, 13 May 2026 16:06:00 -0400 DRMA O.28730328 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Dermata+Therapeutics%2C+++++For%3A+Mar+31/26485894.html si-local-file:///var/storage/secattach/20260513/26485894.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Dermata+Therapeutics%2C+++++For%3A+Mar+31/26485894.html Wed, 13 May 2026 16:06:00 -0400 DRMA O.28730328 http://www.streetinsider.com/Press+Releases/Dermata+Therapeutics+Provides+Corporate+Update+and+Reports+Financial+Results+for+the+First+Quarter+2026/26485787.html <p><i><strong>- Dermata announced their Tome Skincare brand for direct-to-consumer ("DTC") skincare products -</strong></i></p><p><i><strong>- Dermata plans to launch its first DTC product, the Tome Foundational Treatment, a once-weekly mask to support skin renewal, in the middle of 2026 -</strong></i></p><p><i><strong>- Raised $2.0 million in net proceeds from it's at-the-market ("ATM") financing facility -</strong></i></p> <p><strong id="dateline">SAN DIEGO, CA / <a href='https://www.accessnewswire.com/'>ACCESS Newswire</a> / May 13, 2026 / </strong><a rel="nofollow" href="https://pr.report/lj53">Dermata Therapeutics</a>, Inc. (Nasdaq:<a rel="nofollow" href="https://pr.report/lj54">DRMA</a>, DRMAW) ("Dermata," or the "Company"), a science-driven leader in dermatologic solutions, today highlighted recent corporate progress and reported financial results for the http://www.streetinsider.com/Press+Releases/Dermata+Therapeutics+Provides+Corporate+Update+and+Reports+Financial+Results+for+the+First+Quarter+2026/26485787.html Wed, 13 May 2026 16:05:00 -0400 DRMA http://www.streetinsider.com/ACCESS+Newswire/Dermata+Therapeutics+Provides+Corporate+Update+and+Reports+Financial+Results+for+the+First+Quarter+2026/26485787.html <p><i><strong>- Dermata announced their Tome Skincare brand for direct-to-consumer ("DTC") skincare products -</strong></i></p><p><i><strong>- Dermata plans to launch its first DTC product, the Tome Foundational Treatment, a once-weekly mask to support skin renewal, in the middle of 2026 -</strong></i></p><p><i><strong>- Raised $2.0 million in net proceeds from it's at-the-market ("ATM") financing facility -</strong></i></p> <p><strong id="dateline">SAN DIEGO, CA / <a href='https://www.accessnewswire.com/'>ACCESS Newswire</a> / May 13, 2026 / </strong><a rel="nofollow" href="https://pr.report/lj53">Dermata Therapeutics</a>, Inc. (Nasdaq:<a rel="nofollow" href="https://pr.report/lj54">DRMA</a>, DRMAW) ("Dermata," or the "Company"), a science-driven leader in dermatologic solutions, today highlighted recent corporate progress and reported financial results for the http://www.streetinsider.com/ACCESS+Newswire/Dermata+Therapeutics+Provides+Corporate+Update+and+Reports+Financial+Results+for+the+First+Quarter+2026/26485787.html Wed, 13 May 2026 16:05:00 -0400 DRMA